Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth
- PMID: 19901982
- PMCID: PMC2768790
- DOI: 10.1371/journal.pone.0007615
Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth
Abstract
Background: The secretory proteins of Mycobacterium tuberculosis (M. tuberculosis) have been known to be involved in the virulence, pathogenesis as well as proliferation of the pathogen. Among this set, many proteins have been hypothesized to play a critical role at the genesis of the onset of infection, the primary site of which is invariably the human lung.
Methodology/principal findings: During our efforts to isolate potential binding partners of key secretory proteins of M. tuberculosis from a human lung protein library, we isolated peptides that strongly bound the virulence determinant protein Esat6. All peptides were less than fifty amino acids in length and the binding was confirmed by in vivo as well as in vitro studies. Curiously, we found all three binders to be unusually rich in phenylalanine, with one of the three peptides a short fragment of the human cytochrome c oxidase-3 (Cox-3). The most accessible of the three binders, named Hcl1, was shown also to bind to the Mycobacterium smegmatis (M. smegmatis) Esat6 homologue. Expression of hcl1 in M. tuberculosis H37Rv led to considerable reduction in growth. Microarray analysis showed that Hcl1 affects a host of key cellular pathways in M. tuberculosis. In a macrophage infection model, the sets expressing hcl1 were shown to clear off M. tuberculosis in much greater numbers than those infected macrophages wherein the M. tuberculosis was not expressing the peptide. Transmission electron microscopy studies of hcl1 expressing M. tuberculosis showed prominent expulsion of cellular material into the matrix, hinting at cell wall damage.
Conclusions/significance: While the debilitating effects of Hcl1 on M. tuberculosis are unrelated and not because of the peptide's binding to Esat6-as the latter is not an essential protein of M. tuberculosis-nonetheless, further studies with this peptide, as well as a closer inspection of the microarray data may shed important light on the suitability of such small phenylalanine-rich peptides as potential drug-like molecules against this pathogen.
Conflict of interest statement
Figures










Similar articles
-
A three-hybrid system to probe in vivo protein-protein interactions: application to the essential proteins of the RD1 complex of M. tuberculosis.PLoS One. 2011;6(11):e27503. doi: 10.1371/journal.pone.0027503. Epub 2011 Nov 8. PLoS One. 2011. PMID: 22087330 Free PMC article.
-
The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection.Med Hypotheses. 2012 Mar;78(3):389-92. doi: 10.1016/j.mehy.2011.11.022. Epub 2011 Dec 21. Med Hypotheses. 2012. PMID: 22192908
-
Mycobacterium tuberculosis ESAT6 modulates host innate immunity by downregulating miR-222-3p target PTEN.Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166292. doi: 10.1016/j.bbadis.2021.166292. Epub 2021 Oct 25. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 34710568
-
Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells.Mol Microbiol. 2010 Jan;75(1):92-106. doi: 10.1111/j.1365-2958.2009.06959.x. Epub 2009 Nov 10. Mol Microbiol. 2010. PMID: 19906174 Free PMC article.
-
Antimicrobial peptides as drugs with double response against Mycobacterium tuberculosis coinfections in lung cancer.Front Microbiol. 2023 Jun 2;14:1183247. doi: 10.3389/fmicb.2023.1183247. eCollection 2023. Front Microbiol. 2023. PMID: 37342560 Free PMC article. Review.
Cited by
-
Expression of the ARPC4 subunit of human Arp2/3 severely affects mycobacterium tuberculosis growth and suppresses immunogenic response in murine macrophages.PLoS One. 2013 Jul 22;8(7):e69949. doi: 10.1371/journal.pone.0069949. Print 2013. PLoS One. 2013. PMID: 23894563 Free PMC article.
-
A three-hybrid system to probe in vivo protein-protein interactions: application to the essential proteins of the RD1 complex of M. tuberculosis.PLoS One. 2011;6(11):e27503. doi: 10.1371/journal.pone.0027503. Epub 2011 Nov 8. PLoS One. 2011. PMID: 22087330 Free PMC article.
-
A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response.BMC Infect Dis. 2014 Jul 1;14:355. doi: 10.1186/1471-2334-14-355. BMC Infect Dis. 2014. PMID: 24985537 Free PMC article.
-
A novel peptide interferes with Mycobacterium tuberculosis virulence and survival.FEBS Open Bio. 2014 Aug 7;4:735-40. doi: 10.1016/j.fob.2014.08.001. eCollection 2014. FEBS Open Bio. 2014. PMID: 25349777 Free PMC article.
-
Mycobacterium tuberculosis cyclophilin A uses novel signal sequence for secretion and mimics eukaryotic cyclophilins for interaction with host protein repertoire.PLoS One. 2014 Feb 4;9(2):e88090. doi: 10.1371/journal.pone.0088090. eCollection 2014. PLoS One. 2014. PMID: 24505389 Free PMC article.
References
-
- Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. J Am Med Assoc. 1999;282:677–686. - PubMed
-
- Yew WW, Leung CC. Updates in tuberculosis 2007. Am J Respir Crit Care Med. 2008;177:479–485. - PubMed
-
- Khatri GR. Controlling tuberculosis in India. New Engl J Med. 2002;347:1420–1425. - PubMed
-
- Jain A, Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008;53:145–150. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases